The Latin America, Middle East and Africa Dialyzer Market would witness market growth of 7.27% CAGR during the forecast period (2019-2025).
Increased financing for enhanced dialysis products and services, growing cases of diabetes and hypertension, and shortage of kidneys for transplantation are anticipated to further boost the market growth. Although the dialyzer market trends continue to increase, some factors hamper this market's growth. The complications and risks connected with the hemodialysis operation, such as serious anemia and fluid overload, hamper the market growth.
Manufacturing procedures have now permitted greater cut-off dialyzer membranes to be produced. This has enabled comparable diffusion clearances of medium-sized uremic toxins compared to hemodiafiltration without excessive loss of albumin. Although there is no perfect dialyzer that can efficiently clear all kinds of uremic toxins while retaining vitamins and other essential factors, enhancing the variety of uremic toxin clearance is most probable to result in inpatient benefits.
Based on Type, the market is segmented into High-Flux Dialyzer and Low-Flux Dialyzer. Based on End User, the market is segmented into In-Center Dialysis and Home Dialysis. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., CVS Health Corporation, Fresenius Medical Care AG & Co. KGaA, DaVita, Inc., Asahi Kasei Corporation, Cardinal Health, Inc., Cantel Medical Corporation, Nipro Corporation, Allmed Medical Care Holdings Limited and Terumo Corporation.
Market Segmentation:
By Type
By End User
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
